NurExone unit Exo-Top signs MOU with ExoLyra for exclusive Mexico distribution of naive exosomes

  • NurExone’s unit Exo-Top signed a binding MOU with ExoLyra for exclusive distribution of naïve MSC-derived exosomes in Mexico.
  • Parties target a definitive agreement within 45 days; Mexico exclusivity set for three years, extendable to 10 years subject to performance.
  • Deal includes a non-refundable exclusivity fee of USD 180,000; USD 40,000 at signing, USD 140,000 once product is shipment-ready.
  • ExoLyra commits at least USD 800,000 for market entry, including the licensing fee; annual USD 100,000 maintenance fee starts in Year 4.
  • Minimum purchases set at 20,000 units in the first 18 months, rising to 60,000 units from Year 4, with a 5% annual escalator capped at 70,000.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NurExone Biologic Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606241701PRIMZONEFULLFEED9752076) on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.